HighVista Strategies’s Vera Therapeutics VERA Stock Holding History

HighVista Strategies’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.54M	Buy	105,907 +36,666	+53%	+$1.37M	1.04%	29
2026 Q1	$2.79M	Buy	+69,241	New	+$2.98M	0.77%	44
2025 Q4	–	Sell	-91,189	Closed	-$2.65M	–	176
2025 Q3	$2.65M	Buy	91,189 +50,716	+125%	+$1.17M	0.65%	46
2025 Q2	$954K	Sell	40,473 -11,724	-22%	-$264K	0.35%	111
2025 Q1	$1.25M	Hold	52,197	–	–	0.48%	95
2024 Q4	$2.21M	Buy	52,197 +30,187	+137%	+$1.34M	0.82%	38
2024 Q3	$973K	Buy	22,010 +12,848	+140%	+$488K	0.34%	104
2024 Q2	$331K	Buy	+9,162	New	+$363K	0.12%	131
2023 Q4	–	Sell	-30,902	Closed	-$424K	–	149
2023 Q3	$424K	Buy	+30,902	New	+$530K	0.2%	125

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

HighVista Strategies's VERA Position: Q2 2026 in Review

HighVista Strategies increased its Vera Therapeutics (VERA) stake by 53% in Q2 2026, buying an estimated $1.37M and bringing the position to 105,907 shares worth $4.54M. The position accounts for 1.04% of the portfolio, ranked #29.

HighVista Strategies first reported a position in VERA in Q3 2023 and has held it in 9 quarters since. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

HighVista Strategies held 105,907 shares of Vera Therapeutics worth $4.54M as of Q2 2026.
HighVista Strategies bought 36,666 Vera Therapeutics shares in Q2 2026, an estimated $1.37M.
Vera Therapeutics made up 1.04% of HighVista Strategies's portfolio in Q2 2026, its #29 holding.
HighVista Strategies first reported a position in Vera Therapeutics in Q3 2023 and has held it in 9 quarters since.
220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on HighVista Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.